The first ethical issue presented in the ethics game simulation was whether to warn consumers about the contaminated product and what information to provide consumers about the contaminant. The second ethical issue was whether to sell a product that does not meet U.S. safety requirements in a foreign market that has lower safety restrictions. G-BioSport was not required to meet prior approval from the Federal Drug Administration before they released their product on the market. After G-BioSport ran test, it was determined that there were traces of a contaminant in the sample received. The quality control manager must identify a developmental solution to maintain the company’s reputation and identify the problem. G-BioSport had stumble upon a serious problem that required immediate attention. They had just discovered that there were traces of a contaminant in the sample they received. The question at hand is to warn and give the consumers information to provide them about the contaminant. The course of action was to disseminate the information about the risk for specific groups of people in the area. My first concern was to address the contaminated product and decided to provide the consumers with information on the increased risk to allow them to make an informed choice. Consumers have the right to know about the risk they are taking. We don’t always think like the consumer, so therefore we don’t always get the same results as the consumer. We have to remind ourselves that the consumers keep us in business by purchasing our products. Release or publish information decreases the risk of more issues arising and allows the consumers to make their own choices. Company values are embodied in the products sold to consumers therefore we need to make sure it is safe. We will not sell products that don’t meet U.S. safety requirements in a foreign market with lower safety